Third-generation cephalosporins

Cefotaxime

Approved 24 Mar 2000InjectionInjectable

The FDA lists this product in 10 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: CEFOTAXIME SODIUM EQ 1GM BASE/VIAL

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Official product information

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Drugs@FDA lists the approved labels, letters and reviews for application ANDA064200.

Open Drugs@FDA

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Cefotaxime
Active substance: cefotaxime sodium
Drug class: Third-generation cephalosporins
Group: Antibiotics
Route: Injection
Dosage form: Injectable
Applicant: Fresenius Kabi USA
Status: Discontinued
FDA approval: 24 Mar 2000
Application: ANDA064200-002
RxCUI: 2186

Guidelines

Ciprofloxacin HydrochlorideSolution/drops

Pivyapivmecillinam hydrochloride · Tablet

FidaxomicinTablet

Likmezmetronidazole · Suspension

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloridebismuth subcitrate potassium · Capsule

Voquezna Dual Pakamoxicillin · Capsule, tablet

FexinidazoleTablet

ErythromycinTablet, delayed release

Nuzyraomadacycline tosylate · Powder

Arikayce Kitamikacin sulfate · Suspension, liposomal

Cefepime Hydrochloride in Plastic Containercefepime hydrochloride · Powder

Ertapenem SodiumInjectable

Solosecsecnidazole · Granule

Baxdeladelafloxacin meglumine · Tablet

Moxifloxacin Hydrochloride in Sodium Chloride 0.8% in Plastic Containermoxifloxacin hydrochloride · Solution

Zenavoddoxycycline · Capsule